YE6-78204-09054
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 967 / HI
- Registered
- 2021-06-23
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
TQT-25192-43904
Child or adolescent in my care · Female · 2021-06-23
VY5-22809-25123
Child or adolescent in my care · Female · 2021-07-15
Timeline
-
2021-06-23
Registered in v-safe
-
2021-06-23
Dose 1 — Pfizer-BioNTech
-
2021-07-14
Dose 2 — Pfizer-BioNTech
- 2021-07-15
- 2021-07-17
- 2021-07-18
- 2021-07-19
- 2021-07-20
- 2021-07-23
- 2021-07-28
- 2021-08-04
-
2021-08-11
Survey response — day 28, dose 2MedDRA: Injection site pain — Feeling: FairFree text: Site sorenessMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-19
- 2021-08-25
- 2021-10-13
- 2022-01-12
- 2022-07-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-23 | Pfizer-BioNTech | No |
| 2 | 2021-07-14 | Pfizer-BioNTech | No |
Free text
Release 9 — day 28, dose 2
Symptoms: Site soreness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site pain | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release